DAB2IP and breast cancer: miR-556-3p enhances RAS GTPase activity and extracellular signal-related kinases 1 and 2 (ERK1/2) phosphorylation by targeting the down-regulation of DAB2 interacting protein (DAB2IP), and stimulates the proliferation, invasion, migration, and colony formation of BC cells[24].